Back
Lantern Pharma, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
24
LTRN
Lantern Pharma, Inc.
Last Price:
$3.31
Seasonality Move:
3.04%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bearish and LTRN is experiencing selling pressure, which indicates risk of future bearish movement.
Lantern Pharma, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.44 | Sell |
| 20-day SMA: | 3.55 | Sell |
| 50-day SMA: | 3.69 | Sell |
| 200-day SMA: | 3.77 | Sell |
| 8-day EMA: | 3.39 | Sell |
| 20-day EMA: | 3.49 | Sell |
| 50-day EMA: | 3.24 | Buy |
| 200-day EMA: | 1.62 | Buy |
Lantern Pharma, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 39.93 | Sell |
| Chaikin Money Flow: | -36499 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.23 - 3.75) | Sell |
| Bollinger Bands (100): | (3.54 - 4.52) | Sell |
Lantern Pharma, Inc. Technical Analysis
| Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Lantern Pharma, Inc. Stock
Is Lantern Pharma, Inc. Stock a Buy?
-
Lantern Pharma, Inc. share price is 3.26 while LTRN 8-day simple moving average is 3.44, which is a Sell signal.
-
The stock price of LTRN is 3.26 while Lantern Pharma, Inc. 20-day SMA is 3.55, which makes it a Sell.
-
Lantern Pharma, Inc. 50-day simple moving average is 3.69 while LTRN share price is 3.26, making it a Sell technically.
-
LTRN stock price is 3.26 and Lantern Pharma, Inc. 200-day simple moving average is 3.77, creating a Sell signal.
LTRN Technical Analysis vs Fundamental Analysis
Sell
24
Lantern Pharma, Inc. (LTRN)
is a Sell
Is Lantern Pharma, Inc. a Buy or a Sell?
-
Lantern Pharma, Inc. stock is rated a SellThe current Lantern Pharma, Inc. [LTRN] share price is $3.26. The Score for LTRN is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
Lantern Pharma, Inc. Stock Info
Market Cap:
36.5M
Price in USD:
3.26
Share Volume:
40.1K
Lantern Pharma, Inc. 52-Week Range
52-Week High:
6.12
52-Week Low:
2.55
Sell
24
Lantern Pharma, Inc. (LTRN)
is a Sell
Lantern Pharma, Inc. Share Price Forecast
-
What is the Lantern Pharma, Inc. stock price today?The Lantern Pharma, Inc. stock price is 3.26 USD today.
-
Will LTRN stock go up or go down?Lantern Pharma, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Lantern Pharma, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Lantern Pharma, Inc. is overvalued.
Is Lantern Pharma, Inc. Stock a Buy?
-
Lantern Pharma, Inc. share price is 3.26 while LTRN 8-day exponential moving average is 3.39, which is a Sell signal.
-
The stock price of LTRN is 3.26 while Lantern Pharma, Inc. 20-day EMA is 3.49, which makes it a Sell.
-
Lantern Pharma, Inc. 50-day exponential moving average is 3.24 while LTRN share price is 3.26, making it a Buy technically.
-
LTRN stock price is 3.26 and Lantern Pharma, Inc. 200-day simple moving average is 1.62, creating a Buy signal.
Fundamental Analysis of Lantern Pharma, Inc.
Is Lantern Pharma, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.25 per share, and an increase next year of $0.15 per share.
Technical Analysis of Lantern Pharma, Inc.
Should I short Lantern Pharma, Inc. stock?
-
LTRN Moving Average Covergence Divergence (MACD) indicator is -0.04, suggesting Lantern Pharma, Inc. is a Sell
-
Lantern Pharma, Inc. Relative Strength Index (RSI) is 39.93, which suggest Lantern Pharma, Inc. is oversold
-
The Bollinger Bands (25) for Lantern Pharma, Inc. is (3.23 - 3.75), which suggest Lantern Pharma, Inc. is a Sell
-
The Bollinger Bands (100) for Lantern Pharma, Inc. is (3.54 - 4.52), which suggest Lantern Pharma, Inc. is a Sell
* Lantern Pharma, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.